-DOCSTART- -X- O
PURPOSE -X- _ O
OF -X- _ O
REVIEW -X- _ O
: -X- _ O
Hepatic -X- _ B-Patient
ischemia-reperfusion -X- _ I-Patient
injury -X- _ I-Patient
( -X- _ I-Patient
IRI -X- _ I-Patient
) -X- _ I-Patient
, -X- _ O
an -X- _ O
inevitable -X- _ O
event -X- _ O
during -X- _ O
liver -X- _ B-Patient
transplantation -X- _ I-Patient
, -X- _ O
represents -X- _ O
a -X- _ O
major -X- _ O
risk -X- _ O
factor -X- _ O
for -X- _ O
the -X- _ O
primary -X- _ O
graft -X- _ O
dysfunction -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
the -X- _ O
development -X- _ O
of -X- _ O
acute -X- _ O
and -X- _ O
chronic -X- _ O
rejection. -X- _ O
Neutrophils -X- _ O
, -X- _ O
along -X- _ O
macrophages -X- _ O
, -X- _ O
are -X- _ O
pivotal -X- _ O
in -X- _ O
the -X- _ O
innate -X- _ O
immune-driven -X- _ O
liver -X- _ O
IRI -X- _ O
, -X- _ O
whereas -X- _ O
the -X- _ O
effective -X- _ O
neutrophil-targeting -X- _ B-Intervention
therapies -X- _ I-Intervention
remain -X- _ O
to -X- _ O
be -X- _ O
established. -X- _ O
In -X- _ O
this -X- _ O
review -X- _ O
, -X- _ O
we -X- _ O
summarize -X- _ O
progress -X- _ O
in -X- _ O
our -X- _ O
appreciation -X- _ O
of -X- _ O
the -X- _ O
neutrophil -X- _ O
biology -X- _ O
and -X- _ O
discuss -X- _ O
neutrophil-based -X- _ O
therapeutic -X- _ O
perspectives. -X- _ O
RECENT -X- _ O
FINDINGS -X- _ O
: -X- _ O
New -X- _ O
technological -X- _ O
advances -X- _ O
enable -X- _ O
to -X- _ O
accurately -X- _ O
track -X- _ O
neutrophil -X- _ O
movements -X- _ O
and -X- _ O
help -X- _ O
to -X- _ O
understand -X- _ O
molecular -X- _ O
mechanisms -X- _ O
in -X- _ O
neutrophil -X- _ O
function -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
selective -X- _ O
recruitment -X- _ O
to -X- _ O
IR-stressed -X- _ O
tissue -X- _ O
, -X- _ O
formation -X- _ O
of -X- _ O
neutrophil -X- _ O
extracellular -X- _ O
traps -X- _ O
, -X- _ O
or -X- _ O
reverse -X- _ O
migration -X- _ O
into -X- _ O
circulation. -X- _ O
In -X- _ O
addition -X- _ O
to -X- _ O
pro-inflammatory -X- _ O
and -X- _ O
tissue-destructive -X- _ O
functions -X- _ O
, -X- _ O
immune -X- _ O
regulatory -X- _ O
and -X- _ O
tissue-repairing -X- _ O
phenotype -X- _ O
associated -X- _ O
with -X- _ O
distinct -X- _ O
neutrophil -X- _ O
subsets -X- _ O
have -X- _ O
been -X- _ O
identified. -X- _ O
SUMMARY -X- _ O
: -X- _ O
Newly -X- _ B-Outcome
recognized -X- _ I-Outcome
and -X- _ I-Outcome
therapeutically -X- _ I-Outcome
attractive -X- _ I-Outcome
neutrophil -X- _ I-Outcome
characteristics -X- _ I-Outcome
warrant -X- _ I-Outcome
comprehensive -X- _ I-Outcome
preclinical -X- _ I-Outcome
and -X- _ I-Outcome
clinical -X- _ I-Outcome
attention -X- _ I-Outcome
to -X- _ I-Outcome
target -X- _ I-Outcome
IRI -X- _ I-Outcome
in -X- _ I-Outcome
transplant -X- _ I-Outcome
recipients -X- _ I-Outcome
. -X- _ O

